Company Filing History:
1 out of 284 
1 out of 116 
Years Active: 2023
Title: Innovations by Samuel Hertig
Introduction
Samuel Hertig is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the area of tumor and fibrosis diagnosis and therapy. His innovative work has the potential to impact the treatment of diseases associated with abnormal fibronectin accumulation.
Latest Patents
Samuel Hertig holds a patent for "Fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy." This invention is directed to a composition that includes at least one fibronectin binding polypeptide linked to a diagnostic or therapeutic agent. The patent also encompasses a nucleic acid encoding a fusion polypeptide comprising the fibronectin binding polypeptide linked to a diagnostic or therapeutic polypeptide agent. Additionally, it includes a corresponding recombinant vector and host cell that express the fusion polypeptide. The invention aims to provide a kit that comprises the fibronectin binding polypeptide, diagnostic or therapeutic agents, and optional chemical agents for linking these components. This composition is intended for therapeutic or prophylactic treatment of diseases such as cancer, fibrosis, or immune diseases.
Career Highlights
Throughout his career, Samuel Hertig has worked with prestigious institutions, including ETH Zurich and the Paul Scherrer Institute. His experience in these organizations has contributed to his expertise in the field of biomedical innovations.
Collaborations
Samuel has collaborated with notable colleagues, including Mamta Chabria and Alessandra Moscaroli. Their joint efforts have further advanced research in the areas of fibronectin and its applications in medical therapies.
Conclusion
Samuel Hertig's innovative contributions to the field of biomedical research highlight the importance of fibronectin-binding peptides in diagnosing and treating serious diseases. His work continues to pave the way for advancements in therapeutic solutions.